0001209191-14-010442.txt : 20140213 0001209191-14-010442.hdr.sgml : 20140213 20140213165241 ACCESSION NUMBER: 0001209191-14-010442 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131231 FILED AS OF DATE: 20140213 DATE AS OF CHANGE: 20140213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INVACARE CORP CENTRAL INDEX KEY: 0000742112 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 952680965 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 BUSINESS PHONE: 4403296000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SLANGEN LOUIS F J CENTRAL INDEX KEY: 0001233925 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15103 FILM NUMBER: 14606926 BUSINESS ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 BUSINESS PHONE: 4403296000 5 1 doc5.xml FORM 5 SUBMISSION X0306 5 2013-12-31 0 0 0 0000742112 INVACARE CORP IVC 0001233925 SLANGEN LOUIS F J ONE INVACARE WAY ELYRIA OH 44035 0 1 0 0 Senior Vice President Common Shares 35303 D Common Shares 10449.182 I By Invacare Retirement Savings Plan Common Shares 522 I By Spouse Employee Stock Option (Right to Buy) Common Shares 155300 155300 D Owned by the Trustee for the Invacare Retirement Savings Plan. The information given is based on a Plan Statement of December 31, 2013, the most recent information reasonably available. No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5. The reporting person holds previously reported options to buy 155,300 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 24, 2004 and March 18, 2013, at exercise prices between $13.37 and $44.30 per share, will expire between August 24, 2014 and March 18, 2023 and became or will become exercisable between September 30, 2005 and March 31, 2017. /s/ Louis F. J. Slangen, by Kristofer K. Spreen, his attorney-in-fact pursuant to Power of Attorney, dated February 12, 2009, on file with the Commission 2014-02-13